PARTNERSHIP OPPORTUNITIES
Partnering with the 5th Inner Ear Disorders Therapeutics Summit presents a unique opportunity to position your organization at the forefront of hearing loss research and innovation.
This annual event unites top biotech leaders, pharma stakeholders, medical device manufacturers, and academic pioneers, offering unparalleled visibility and networking prospects.
As a partner, you can showcase your expertise, build strategic partnerships, and engage with key decision-makers shaping the future of inner ear therapeutics. Your support will drive groundbreaking advancements in gene therapy, cell-based treatments, and drug-device combinations, ultimately improving patient outcomes and expanding the market for novel hearing loss solutions.
Current Partners:
What Experts Need from You:
Preclinical CROs – Collaborate with biopharma companies looking for specialized expertise in advancing inner ear therapeutics from early discovery through IND-enabling studies. By providing critical preclinical services, including pharmacokinetics, toxicology, and efficacy assessments, CROs play a pivotal role in ensuring robust validation and de-risking programs before clinical transition.
Preclinical Models – Showcase cutting-edge in vitro and in vivo models specifically designed to mimic inner ear physiology and pathology, enabling more predictive translational research. These advanced models help drug developers refine their therapeutic approaches, ensuring greater accuracy in evaluating drug efficacy and safety before moving into human trials.
Diagnostic Audiology – Engage with leading experts in diagnostic audiology to explore novel hearing assessment technologies that improve patient stratification and trial outcomes. With better biomarkers and precision diagnostics, companies can enhance recruitment strategies, measure therapeutic efficacy more effectively, and accelerate clinical success.
Drug Delivery – Present breakthrough drug delivery technologies, from nanoparticle-based formulations to implantable devices, designed to overcome the complex barriers of inner ear drug targeting. These innovations optimize bioavailability, improve therapeutic precision, and expand the potential of gene and small molecule therapies for hearing restoration.
Clinical CROs – Establish yourself as a critical partner in the clinical development of hearing loss therapeutics by offering expertise in trial design, regulatory navigation, and patient recruitment strategies. With specialized knowledge in executing audiology-focused trials, clinical CROs help streamline the transition from preclinical research to successful regulatory approval and commercialization.
Why Partner?
Stay Ahead with Cutting-Edge Insights in Inner Ear Drug Discovery- Gain exclusive access to the latest advancements in hearing loss therapeutics from leading companies such as Sound Pharmaceuticals, Ting Therapeutics, and Rinri Therapeutics. Expand your knowledge and refine your target client list with direct connections to industry pioneers shaping the future of inner ear treatment.
Build High-Value Connections with Decision-Makers from Top Biotech & Pharma- Engage in meaningful discussions with executives and researchers from Acousia Therapeutics, Sensorion, Lineage Cell Therapeutics, Regeneron, and more. This is your opportunity to connect with companies actively seeking preclinical, biomarker, pathology, and clinical services to drive their drug development forward.
Unlock New Business & Commercial Collaborations in the Expanding Inner Ear Space- Leverage this summit to initiate and nurture strategic partnerships with companies newly entering the field of inner ear therapeutics. Ensure that your most promising prospects are in the room and primed for collaboration, setting the stage for high-value commercial opportunities.
Maximize Brand Visibility Among Key Stakeholders in Otolaryngology & Auditory Sciences- Position your organization as a leader in the field by leveraging exclusive branding opportunities, including event sponsorships, keynote presentations, and exhibition booths. Stand out to top researchers, biotech innovators, and pharmaceutical executives actively working on the next wave of hearing loss treatments.
Who Will You Meet?
